Abstract:AIM:Point mutation, one of the commonest gene mutations, is the most important molecular pathogenesis of cancer and chronic infection. The commonest methods for detection of point mutation are based on polymerase chain reaction (PCR). These techniques, however, cannot be used in large scale screening since they are neither accurate nor simple. For this reason, this study established a novel method of competitively differentiated PCR (CD-PCR) for screening point mutation in clinical practice.METHODS:Two competitively differentiated primers for mutant-type and wild-type templates respectively with an identically complemented region in 3' end except for last 2 base pairs and a different non-complemented region in 5' end were designed. Thus, competitive amplification might be carried out at a lower annealing temperature at first, and then differentiated amplification at a higher annealing temperature when primers could not combine with initial templates. The amplification was performed in one-tube. The products of CD-PCR were detected using microplate hybridization assay. CD-PCR was evaluated by detecting G1896A variant of hepatitis B virus (HBV) in form of recombinant plasmids and in sera from patients with hepatitis B, and compared with allele-specific PCR (AS-PCR) and competitive AS-PCR.RESULTS:CD-PCR was successfully established. It could clearly distinguish wild-type and mutant-type plasmid DNA of G1896A variant when the amount of plasmid DNA was between 10(2)-10(8)copies/reaction, while for AS-PCR and competitive AS-PCR, the DNA amount was between 10(2)-10(4)copies/reaction. CD-PCR could detect one copy of G1896A variant among 10-100 copies of wild-type plasmid DNA. The specificity of CD-PCR was higher than those of AS-PCR and competitive AS-PCR in the detection of HBV G1896A variant in sera from patients with hepatitis B. CD-PCR was independent of the amount of HBV DNA in serum. HBV G1896A variant was more often found in HBeAg (-) patients with a lower level of detectable viremia than that with a higher level of detectable viremia (P=0.0192).CONCLUSION:CD-PCR is more specific since it is less influenced by the amount of initial templates and the cross amplification between mutant- and wild-type amplified products. It is also simple and time-saving. Thus, CD-PCR might be useful in routine gene typing and point mutation screening. HBV G1896A or other more important mutations have to be routinely detected in patients with a detectable level of viremia after HBeAg/antibody conversion in clinical practice.

Development and application of a reverse hybridization method for detection of hepatitis B virus precore mutation associated with hepatocellular carcinoma

Analysis of suspicious results of serum HBV DNA detected by fluorescence quantitative PCR

Novel Approach to Identifying the Hepatitis B Virus Pre-S Deletions Associated with Hepatocellular Carcinoma

Reverse Line Probe Hybridization Assay for Detection of Lamivudine-Resistant Chronic Hepatitis B Virus

A novel assay for detecting the mutation of nucleotide 1758-1777 deletion in core promoter region of hepatitis B virus

Detection of A1762T/G1764A mutations in the basic core promoter of hepatitis B virus by reverse dot blot hybridization

High Prevalence of Hepatitis B Virus Pre-S Mutation and Its Association with Hepatocellular Carcinoma in Qidong, China.

Nested real-time quantitative polymerase chain reaction assay for detection of hepatitis B virus covalently closed circular DNA

Dectetion of Preneoplastic Markers of Hepatitis B Virus-Associated Hepatocellular Carcinoma

Novel Assay of Competitively Differentiated Polymerase Chain Reaction for Screening Point Mutation of Hepatitis B Virus.

In-Situ Mutation Detection by Magnetic Beads-Probe Based on Single Base Extension and Its Application in Genotyping of Hepatitis B Virus Pre-C Region 1896nt Locus Single Nucleotide Polymorphisms.

Comparison Study on the Complete Sequence of Hepatitis B Virus Identifies New Mutations in Core Gene Associated with Hepatocellular Carcinoma

Mutation of Hepatitis B Virus Precore/basal Core Promoter in 234 Patients with Chronic Hepatitis

Development of Method for Detection of Specific Antibodies of Hepatitis B Virus X Gene Deletion Mutants HBx-d382 and HBx-d431 and Evaluation of its Clinical Use

Study on the Complete Sequence of Hepatitis B s Identifies New Mutations in Core Gene Associated with B & P atocellular Carcinoma

DETECTION OF GENE MUTATIONS IN HBV PRECORE AND BASIC CORE PROMOTER REGION USING MICROARRAY TECHNIQUE

Analysis of HBV Precore 1896 Site Mutation and Its HBV Genotype and Other Laboratory Features

[Establishment and Application of Nested Real-Time Quantitative Polymerase Chain Reaction Assay for Detection of Hepatitis B Virus Covalently Closed Circular DNA].

Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China.

Analysis of hepatitis B virus pre-C G1896A mutation in person with BeAg-negative chronic HBV infection

[A Quantitative Real Time Polymerase Chain Reaction for Detection of HBV Covalently Closed Circular DNA in Livers of the HBV Infected Patients].